Hubert T. Faber

Learn More
OBJECTIVE This study assesses soft tissue reactions and implant stability of 1,132 percutaneous titanium implants (970 patients) for bone conduction devices (BCDs). In addition, it examines BCD usage and comparisons between different patient groups. STUDY DESIGN Retrospective survey. Mean follow-up time of 4.6 years. SETTING Tertiary care referral(More)
OBJECTIVE To clinically evaluate the performance of a titanium percutaneous bone-anchored hearing implant (BAHI) using a 3-week healing period. Short-term implant survival, stability changes, and skin reactions are evaluated from the initial implantation to 6 months postimplantation. METHODS Thirty patients eligible for a BAHI were included in an open,(More)
The objective of this study was to ascertain the long-term safety of loading osseointegrated implants for bone conduction hearing 3 weeks post-surgery. Thirty consecutive adult patients were implanted with the Baha BI300 (Cochlear Bone Anchored Solutions) in our tertiary referral center. Implants were loaded with the sound processor 3 weeks post-surgery.(More)
OBJECTIVE To identify risk factors for complications after bone-anchored hearing implant (BAHI) surgery. STUDY DESIGN Retrospective cohort study. SETTING Tertiary referral center. PATIENTS All adult patients who received titanium bone-anchored hearing implants at our clinic between September 1, 1988 and December 31, 2007 were approached to fill out a(More)
OBJECTIVE The aim of this study is to evaluate whether diabetes mellitus (DM) is a risk factor for titanium fixture loss in bone-conduction devices (BCDs) because of osseointegration failure. STUDY DESIGN Retrospective case study. SETTING Tertiary referral center. PATIENTS All patients who received a BCD at Nijmegen between January 1, 1988, and(More)
  • 1